Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH

NCT05023824 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Hyperplasia
Prostate Hyperplasia
Prostatic Hypertrophy

Interventions

DRUG: alpha-blocker or 5-ARI withdrawal
DRUG: Maintenance of alpha-blocker and 5-ARI

Sponsor

Gangnam Severance Hospital